Navigation Links
FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics' Unique Proprietary Chemistry
Date:6/25/2008

atment of age-related macular degeneration (AMD), and a number of other indications. This compound entered the clinic in early 2007. Silence Therapeutics also has licensed to Quark rights to the AtuRNAi structure for its proprietary compound, AKIi-5. This Quark compound is in a Phase I human clinical study for treatment of acute kidney injury.

Silence Therapeutics is based in London, UK, and Berlin, Germany, and is listed on AIM.

About RNAi

RNA interference (RNAi) is a Nobel Prize winning technology and one of the most exciting areas of drug discovery today. It represents a completely new approach to selectively 'silence' or inactivate disease relevant genes and as such it has the potential to create a new class of therapeutic products. RNAi could therefore offer a therapeutic approach to a broad range of diseases (cancer, infectious diseases, inherited diseases), many of which have been regarded as incurable and are not addressed by current therapeutics, therefore providing a large market opportunity.

Forward-Looking Statements

This press release includes forward-looking statements that are subject to risks, uncertainties and other factors. These risks and uncertainties could cause actual results to differ materially from those referred to in the forward-looking statements. All forward--looking statements are based on information currently available to Silence Therapeutics and Silence Therapeutics assumes no obligation to update any such forward-looking statements.


'/>"/>
SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
2. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
3. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
4. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
5. FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
6. Maryland Approves Medicaid Reimbursement for ActiPatch(R)
7. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care
8. Medicare Approves in Home Sleep Apnea Testing
9. 3SBio Inc. Approves Share Repurchase Program
10. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
11. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Basel, Switzerland (PRWEB) May 22, 2013 ... solutions for industrial biotechnology, drug discovery, and life ... Genedata Selector â„¢ as its bioinformatics ... its production-relevant organisms. Genedata will provide AB Enzymes, ... manufacturers, with a hosted solution of Genedata Selector ...
(Date:5/22/2013)... 2013 Alton Housing Authority was hit by ... said that their presence has already caused the company ... avoid such big spending, My Cleaning Products shared a way ... was said in the report that to clear the ... from that, its employees also attended a mandatory training on ...
(Date:5/21/2013)... 22, 2013 First patients dosed ... glycopyrronium bromide designed using Prosonix, particle engineering platform ... portfolio of inhaled Respiratory Medicines by Design , ... that will assess its effect on lung function and ... with moderate to severe chronic obstructive pulmonary disease (COPD). ...
(Date:5/21/2013)... The results of a new study led by ... computational evidence that nucleation of ice in small ... understanding water,s behavior at the nanoscale. The formation ... basic scientific research question whose answer also has ... , The crystallization of ice from supercooled ...
Breaking Biology Technology:AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2
... Terumo Heart, Inc. is pleased to,announce the appointment of ... and President, effective immediately. "With its innovative,mag-lev technology, Terumo ... future treatment of heart failure. I am excited to ... trials in up to 40 clinical sites,and further capitalize ...
... China, Nov. 24 3SBio Inc. (Nasdaq: ... and marketing biopharmaceutical products primarily in China,announced that Dr. ... Jaffray 20th Annual Health Care Conference in New York ... The presentation will ...
... FRANCISCO, Nov. 24 Diagnostic Imaging will produce its,11th ... the upcoming,Radiology Society of North America Scientific Assembly and ... through December 5th. This,popular resource will feature daily ... DiagnosticImaging.com. , "The ...
Cached Biology Technology:Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President 2Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008 2
(Date:5/21/2013)... that the nation,s land and water resources could likely ... to 25 billion gallons of algae-based fuel a year ... needs. , The findings come from an in-depth look ... grow significant amounts of algae in large, specially built ... 7 issue of Environmental Science and Technology , ...
(Date:5/21/2013)... become most deadly when they metastasize and spread tumors ... it becomes very difficult for doctors to locate and ... at the University of Missouri have found a way ... wherever they may be in the body. Michael Lewis, ... of Veterinary Medicine, says being able to target secondary ...
(Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2Fueling fitness on the final frontier 2
... During periods of fasting, brain cells responsible for stimulating ... a new study of mice reported in the January ... Press, reveals the complex series of molecular events that ... a link between active thyroid hormone in the brain ...
... bounty in the Eastern Pacific—approximately 50 percent of the ... The research team spent 11 days in the Eastern ... Panama. , Coordinated by Rachel Collin of ... scientists and international collaborators with expertise in snails, crabs, ...
... Wake Forest University School of Medicine are the first ... in prostate and breast cancer cells that may make ... that emotional stress may contribute to the development of ... treatments," said George Kulik, D.V.M., Ph.D., an assistant professor ...
Cached Biology News:How appetite-stimulating brain cells work overtime during fasting 2How appetite-stimulating brain cells work overtime during fasting 3Smithsonian scientists discover new marine species in eastern Pacific 2Stress may help cancer cells resist treatment, research shows 2
Anti-Salmonid Ig (H), Alk Phos, (Clone IPA5F12) (mouse IgG2a)...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
TUP1 Market Segment: Molecular Biology...
... UbcH7 interacts with the HECT ... RING domain. Evidence suggests that ... both the degradation of non-""N-end ... certain N-a -acetylated proteins as ...
Biology Products: